Processa Pharmaceuticals, Inc. PCSA
1.92 USD +0.07 (+3.78%)
Nov 3, 2026, 3:47 PM EST
1.78 Day range 1.94
1.04 52-week range 9.30
- YTD
- -33.33%
- 1 year
- -79.24%
Analyst view
Price target (mean) 6.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.92 | -0.92 – -0.92 | -8.14 | +88.7% | 0 | 0.0% | 1 |
| Next quarter | -0.77 | -0.77 – -0.77 | -1.11 | +30.6% | 0 | 0.0% | 1 |
| Current year | -4.05 | -4.05 – -4.05 | -8.48 | +52.2% | 0 | 0.0% | 1 |
| Next year | -2.16 | -2.16 – -2.16 | -4.05 | +46.7% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 25, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 6, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |